GE HealthCare Technologies (GEHC) Competitors

$60.76 -1.91 (-3.05%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$60.82 +0.05 (+0.09%)

As of 05/15/2026 07:59 PM Eastern

GEHC vs. PHG, MDLN, ZBH, SNN, and SOLV

Should you buy GE HealthCare Technologies stock or one of its competitors? MarketBeat compares GE HealthCare Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with GE HealthCare Technologies include Koninklijke Philips (PHG), Medline (MDLN), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), and Solventum (SOLV). These companies are all part of the "medical equipment" industry.

How does GE HealthCare Technologies compare to Koninklijke Philips?

Koninklijke Philips (NYSE:PHG) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

GE HealthCare Technologies has a net margin of 9.10% compared to Koninklijke Philips' net margin of 5.49%. GE HealthCare Technologies' return on equity of 20.46% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	5.49%	13.51%	5.48%
GE HealthCare Technologies	9.10%	20.46%	5.73%

GE HealthCare Technologies has a consensus price target of $80.67, indicating a potential upside of 32.76%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
GE HealthCare Technologies	1 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.41

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

GE HealthCare Technologies has higher revenue and earnings than Koninklijke Philips. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$17.64B	1.38	$1.01B	$1.17	21.55
GE HealthCare Technologies	$20.98B	1.32	$2.08B	$4.18	14.54

Koninklijke Philips pays an annual dividend of $0.86 per share and has a dividend yield of 3.4%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Koninklijke Philips pays out 73.5% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years.

In the previous week, GE HealthCare Technologies had 15 more articles in the media than Koninklijke Philips. MarketBeat recorded 16 mentions for GE HealthCare Technologies and 1 mentions for Koninklijke Philips. GE HealthCare Technologies' average media sentiment score of 0.87 beat Koninklijke Philips' score of 0.66 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GE HealthCare Technologies	5 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive

Koninklijke Philips has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market.

Summary

GE HealthCare Technologies beats Koninklijke Philips on 15 of the 18 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Medline?

Medline (NASDAQ:MDLN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

GE HealthCare Technologies has a net margin of 9.10% compared to Medline's net margin of 0.00%. GE HealthCare Technologies' return on equity of 20.46% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medline	N/A	N/A	N/A
GE HealthCare Technologies	9.10%	20.46%	5.73%

Medline presently has a consensus price target of $50.85, indicating a potential upside of 40.50%. GE HealthCare Technologies has a consensus price target of $80.67, indicating a potential upside of 32.76%. Given Medline's stronger consensus rating and higher possible upside, equities research analysts plainly believe Medline is more favorable than GE HealthCare Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medline	0 Sell rating(s)	6 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.86
GE HealthCare Technologies	1 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.41

82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

GE HealthCare Technologies has lower revenue, but higher earnings than Medline.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medline	$28.43B	1.67	N/A	N/A	N/A
GE HealthCare Technologies	$20.98B	1.32	$2.08B	$4.18	14.54

In the previous week, GE HealthCare Technologies had 11 more articles in the media than Medline. MarketBeat recorded 16 mentions for GE HealthCare Technologies and 5 mentions for Medline. GE HealthCare Technologies' average media sentiment score of 0.87 beat Medline's score of 0.43 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medline	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
GE HealthCare Technologies	5 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive

Summary

GE HealthCare Technologies beats Medline on 7 of the 13 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Zimmer Biomet?

GE HealthCare Technologies (NASDAQ:GEHC) and Zimmer Biomet (NYSE:ZBH) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

GE HealthCare Technologies currently has a consensus price target of $80.67, suggesting a potential upside of 32.76%. Zimmer Biomet has a consensus price target of $102.80, suggesting a potential upside of 22.78%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe GE HealthCare Technologies is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	1 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.41
Zimmer Biomet	3 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.26

GE HealthCare Technologies has a net margin of 9.10% compared to Zimmer Biomet's net margin of 9.05%. GE HealthCare Technologies' return on equity of 20.46% beat Zimmer Biomet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	9.10%	20.46%	5.73%
Zimmer Biomet	9.05%	13.24%	7.28%

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 1.1%. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Zimmer Biomet pays out 24.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

GE HealthCare Technologies has higher revenue and earnings than Zimmer Biomet. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$20.98B	1.32	$2.08B	$4.18	14.54
Zimmer Biomet	$8.23B	1.97	$705.20M	$3.85	21.75

82.1% of GE HealthCare Technologies shares are held by institutional investors. Comparatively, 88.9% of Zimmer Biomet shares are held by institutional investors. 0.4% of GE HealthCare Technologies shares are held by company insiders. Comparatively, 1.3% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, GE HealthCare Technologies had 5 more articles in the media than Zimmer Biomet. MarketBeat recorded 16 mentions for GE HealthCare Technologies and 11 mentions for Zimmer Biomet. GE HealthCare Technologies' average media sentiment score of 0.87 beat Zimmer Biomet's score of 0.71 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	5 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
Zimmer Biomet	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

GE HealthCare Technologies has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, Zimmer Biomet has a beta of 0.48, meaning that its stock price is 52% less volatile than the broader market.

Summary

GE HealthCare Technologies beats Zimmer Biomet on 13 of the 20 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

Smith & Nephew SNATS currently has a consensus price target of $30.93, suggesting a potential upside of 4.64%. GE HealthCare Technologies has a consensus price target of $80.67, suggesting a potential upside of 32.76%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.40
GE HealthCare Technologies	1 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.41

GE HealthCare Technologies has a net margin of 9.10% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 20.46% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
GE HealthCare Technologies	9.10%	20.46%	5.73%

Smith & Nephew SNATS pays an annual dividend of $0.93 per share and has a dividend yield of 3.1%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.16B	2.05	$625M	N/A	N/A
GE HealthCare Technologies	$20.98B	1.32	$2.08B	$4.18	14.54

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, GE HealthCare Technologies had 16 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 16 mentions for GE HealthCare Technologies and 0 mentions for Smith & Nephew SNATS. GE HealthCare Technologies' average media sentiment score of 0.87 beat Smith & Nephew SNATS's score of 0.34 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Smith & Nephew SNATS	Neutral
GE HealthCare Technologies	Positive

Smith & Nephew SNATS has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

Summary

GE HealthCare Technologies beats Smith & Nephew SNATS on 13 of the 18 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Solventum?

Solventum (NYSE:SOLV) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

Solventum currently has a consensus target price of $84.25, suggesting a potential upside of 13.46%. GE HealthCare Technologies has a consensus target price of $80.67, suggesting a potential upside of 32.76%. Given GE HealthCare Technologies' higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.50
GE HealthCare Technologies	1 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.41

Solventum has a net margin of 17.33% compared to GE HealthCare Technologies' net margin of 9.10%. Solventum's return on equity of 23.51% beat GE HealthCare Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	17.33%	23.51%	7.63%
GE HealthCare Technologies	9.10%	20.46%	5.73%

GE HealthCare Technologies has higher revenue and earnings than Solventum. Solventum is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.33B	1.54	$1.56B	$8.16	9.10
GE HealthCare Technologies	$20.98B	1.32	$2.08B	$4.18	14.54

In the previous week, GE HealthCare Technologies had 5 more articles in the media than Solventum. MarketBeat recorded 16 mentions for GE HealthCare Technologies and 11 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 0.87 beat Solventum's score of 0.37 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solventum	1 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
GE HealthCare Technologies	5 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive

Solventum has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market.

82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.2% of Solventum shares are owned by insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

GE HealthCare Technologies beats Solventum on 9 of the 15 factors compared between the two stocks.

Get GE HealthCare Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GEHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GEHC vs. The Competition

Export

Metric	GE HealthCare Technologies	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$28.51B	$8.14B	$6.43B	$12.48B
Dividend Yield	0.23%	2.52%	2.80%	5.25%
P/E Ratio	14.54	15.81	20.38	25.24
Price / Sales	1.32	6.22	566.19	82.47
Price / Cash	10.66	16.89	43.04	56.04
Price / Book	2.59	3.78	9.87	6.90
Net Income	$2.08B	$223.05M	$3.57B	$334.66M
7 Day Performance	-4.27%	-3.49%	0.31%	0.13%
1 Month Performance	-16.99%	-0.58%	-1.27%	1.11%
1 Year Performance	-16.92%	-0.20%	33.54%	30.62%

GE HealthCare Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GEHC GE HealthCare Technologies	4.9482 of 5 stars	$60.76 -3.0%	$80.67 +32.8%	-16.7%	$28.51B	$20.98B	14.54	54,000	Insider Trade
PHG Koninklijke Philips	2.4718 of 5 stars	$26.75 -1.7%	N/A	+3.6%	$26.20B	$20.17B	22.92	65,340
MDLN Medline	4.2328 of 5 stars	$39.25 -0.7%	$50.69 +29.2%	N/A	$51.92B	$28.43B	N/A	43,000	Analyst Forecast
ZBH Zimmer Biomet	4.4392 of 5 stars	$79.67 -3.2%	$102.80 +29.0%	-13.4%	$15.93B	$8.23B	20.69	17,000	Positive News
SNN Smith & Nephew SNATS	2.2748 of 5 stars	$29.12 -2.8%	$30.93 +6.2%	+2.9%	$12.79B	$6.16B	N/A	16,988

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GEHC) was last updated on 5/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GE HealthCare Technologies (GEHC) Competitors

GEHC vs. PHG, MDLN, ZBH, SNN, and SOLV

How does GE HealthCare Technologies compare to Koninklijke Philips?

Summary

How does GE HealthCare Technologies compare to Medline?

Summary

How does GE HealthCare Technologies compare to Zimmer Biomet?

Summary

How does GE HealthCare Technologies compare to Smith & Nephew SNATS?

Summary

How does GE HealthCare Technologies compare to Solventum?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GEHC vs. The Competition

GE HealthCare Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

GE HealthCare Technologies (GEHC) Competitors

GEHC vs. PHG, MDLN, ZBH, SNN, and SOLV

How does GE HealthCare Technologies compare to Koninklijke Philips?

Is PHG or GEHC more profitable?

Do analysts prefer PHG or GEHC?

Do institutionals & insiders have more ownership in PHG or GEHC?

Which has preferable earnings & valuation, PHG or GEHC?

Is PHG or GEHC a better dividend stock?

Does the media refer more to PHG or GEHC?

Which has more volatility and risk, PHG or GEHC?

Summary

How does GE HealthCare Technologies compare to Medline?

Is MDLN or GEHC more profitable?

Do analysts prefer MDLN or GEHC?

Do insiders and institutionals have more ownership in MDLN or GEHC?

Which has stronger valuation and earnings, MDLN or GEHC?

Does the media prefer MDLN or GEHC?

Summary

How does GE HealthCare Technologies compare to Zimmer Biomet?

Do analysts recommend GEHC or ZBH?

Is GEHC or ZBH more profitable?

Is GEHC or ZBH a better dividend stock?

Which has stronger valuation and earnings, GEHC or ZBH?

Do institutionals & insiders have more ownership in GEHC or ZBH?

Does the media prefer GEHC or ZBH?

Which has more risk and volatility, GEHC or ZBH?

Summary

How does GE HealthCare Technologies compare to Smith & Nephew SNATS?

Do analysts recommend SNN or GEHC?

Is SNN or GEHC more profitable?

Is SNN or GEHC a better dividend stock?

Which has preferable valuation & earnings, SNN or GEHC?

Do institutionals and insiders hold more shares of SNN or GEHC?

Does the media favor SNN or GEHC?

Which has more risk & volatility, SNN or GEHC?

Summary

How does GE HealthCare Technologies compare to Solventum?

Do analysts prefer SOLV or GEHC?

Is SOLV or GEHC more profitable?

Which has higher earnings and valuation, SOLV or GEHC?

Does the media refer more to SOLV or GEHC?

Which has more risk & volatility, SOLV or GEHC?

Do institutionals & insiders hold more shares of SOLV or GEHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GEHC vs. The Competition

GE HealthCare Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools